When.com Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Long-Acting HIV Treatment Backed By GSK, Pfizer Scores ... - AOL

    www.aol.com/news/long-acting-hiv-treatment...

    The FDA has approved ViiV Healthcare's Apretude, the first and only long-acting injectable pre-exposure prophylaxis (PrEP) option, to reduce the risk of sexually acquired HIV-1. The long-acting ...

  3. Pfizer's Lorlatinib Scores European Approval In ALK-Positive ...

    www.aol.com/news/pfizers-lorlatinib-scores...

    The European Commission has approved Pfizer Inc's (NYSE: PFE) Lorviqua (lorlatinib) for a form of advanced non-small-cell lung cancer (NSCLC). Lorlatinib is available in the U.S. under the brand ...

  4. Pfizer CEO: 2023 will be a 'pivotal year' as COVID-19 drug ...

    www.aol.com/finance/pfizer-ceo-2023-pivotal...

    Pfizer is due to report its third-quarter earnings on Nov. 1. Julie Hyman is the co-anchor of Yahoo Finance Live, weekdays 9am-11am ET . Follow her on Twitter @juleshyman , and read her other stories.

  5. Tofacitinib - Wikipedia

    en.wikipedia.org/wiki/Tofacitinib

    RA results from a complex interplay of genetic and environmental factors. Some known influences include: Genetics: Family history can increase susceptibility. Lifestyle: Smoking is a strong environmental factor that can trigger or worsen RA. Diet and Weight: Diets low in vitamin C and high in red meat may raise RA risk, as does obesity.

  6. Cowichan Valley Regional District - Wikipedia

    en.wikipedia.org/wiki/Cowichan_Valley_Regional...

    www.cvrd.ca The Cowichan Valley Regional District is a regional district in the Canadian province of British Columbia that is on the southern part of Vancouver Island , [ 3 ] bordered by the Nanaimo and Alberni-Clayoquot Regional Districts to the north and northwest, and by the Capital Regional District to the south and east.

  7. Palbociclib - Wikipedia

    en.wikipedia.org/wiki/Palbociclib

    Palbociclib, sold under the brand name Ibrance among others, is a medication developed by Pfizer for the treatment of HR-positive and HER2-negative breast cancer.It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.

  8. Pfizer CEO: 2023 will be a 'pivotal year' as COVID-19 drug ...

    www.aol.com/news/pfizer-ceo-2023-pivotal-year-as...

    COVID-19 gave a shot in the arm to Pfizer's sales and culture. Now CEO Albert Bourla lays out a plan to replace vaccine revenue as the virus' impact wanes.

  9. 2023 Canadian electoral calendar - Wikipedia

    en.wikipedia.org/wiki/2023_Canadian_electoral...

    October 2: 2023 Jean-Talon provincial by-election; October 3: 2023 Manitoba general election; 2023 Speaker of the House of Commons of Canada election; October 8: Municipal by-election for councillor #6 in L'Île-Dorval, for councillor #3 in Paspébiac, and for councillors #1, #4, #5, and #6, Sainte-Apolline-de-Patton